Relay Therapeutics (RLAY) Intangibles (2021 - 2025)

Relay Therapeutics (RLAY) has 5 years of Intangibles data on file, last reported at $2.3 million in Q1 2025.

• On a quarterly basis, Intangibles changed 0.0% year-over-year to $2.3 million in Q1 2025; TTM through Mar 2025 was $2.3 million, a 0.0% change from a year earlier, with the FY2024 full-year figure at $2.3 million, changed 0.0% from the prior year.
• Intangibles for Q1 2025 stood at $2.3 million, roughly flat from $2.3 million in the prior quarter.
• Over the last five years, Intangibles for RLAY reached as high as $2.3 million in Q2 2021 and fell as low as $2.3 million in Q2 2021.
• Historically, Intangibles has averaged $2.3 million across 5 years, with a median of $2.3 million in 2021.
• On a YoY basis, Intangibles climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
• Year by year, Intangibles stood at $2.3 million in 2021, then changed by 0.0% to $2.3 million in 2022, then changed by 0.0% to $2.3 million in 2023, then changed by 0.0% to $2.3 million in 2024, then changed by 0.0% to $2.3 million in 2025.
• Per Business Quant data, the three most recent Intangibles figures were $2.3 million in Q1 2025, $2.3 million in Q4 2024, and $2.3 million in Q3 2024.